5-(4-cyanophenoxy)-2,3-dihydro-1-hydroxy-2,1-benzoxaborole

Independent reference data for 5-(4-cyanophenoxy)-2,3-dihydro-1-hydroxy-2,1-benzoxaborole (CAS 906673-24-3), compiled from public chemistry databases.

Registry identifiers across databases

Computed descriptors

Documented uses on record

Intended for the topical treatment of mild to moderate atopic dermatitis in patients 2 years of age and older.Breast Feeding; Lactation; Milk, Human; Enzyme Inhibitors; Phosphodiesterase Inhibitors

Synonyms and trade names

Crisaborole; 906673-24-3; AN-2728; AN2728; Eucrisa; AN 2728; Staquis; crisaborol; Crisaborole topical ointment 2%; 4-[(1-hydroxy-3H-2,1-benzoxaborol-5-yl)oxy]benzonitrile; Q2R47HGR7P; 4-[(1-hydroxy-1,3-dihydro-2,1-benzoxaborol-5-yl)oxy]benzonitrile; CHEBI:134677; DTXSID10238231; 4-((1-Hydroxy-1,3-dihydrobenzo(c)(1,2)oxaborol-6-yl)oxy)benzonitrile; Benzonitrile, 4-((1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy)-

Regulatory listings held on file

GHS notification summary	6.5% (2 / 31)

GHS hazard classification

GHS notification summary	6.5% (2 / 31)
Reported hazard statements	H302 (93.5%), H315 (90.3%), H319 (93.5%)

This chemical does not meet GHS hazard criteria for 6.5% (2 of 31) of reports.

H302 (93.5%): Harmful if swallowed [Warning Acute toxicity, oral]

What the public record says

5-(4-cyanophenoxy)-2,3-dihydro-1-hydroxy-2,1-benzoxaborole · CAS 906673-24-3 · C14H10BNO3. UNII Q2R47HGR7P.

Physical description and handling notes

Source: PubChem / Wikidata; the batch COA governs where values differ.